270 related articles for article (PubMed ID: 34034683)
1. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
Ringland C; Schweig JE; Eisenbaum M; Paris D; Ait-Ghezala G; Mullan M; Crawford F; Abdullah L; Bachmeier C
BMC Neurosci; 2021 May; 22(1):39. PubMed ID: 34034683
[TBL] [Abstract][Full Text] [Related]
2. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
[TBL] [Abstract][Full Text] [Related]
3. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
4. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease.
Lin AL; Parikh I; Yanckello LM; White RS; Hartz AMS; Taylor CE; McCulloch SD; Thalman SW; Xia M; McCarty K; Ubele M; Head E; Hyder F; Sanganahalli BG
Neurobiol Dis; 2020 Jun; 139():104834. PubMed ID: 32173556
[TBL] [Abstract][Full Text] [Related]
5. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
6. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
7. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
[TBL] [Abstract][Full Text] [Related]
8. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
9. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
11. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
12. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
14. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
Wu PJ; Hung YF; Liu HY; Hsueh YP
Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
17. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
[TBL] [Abstract][Full Text] [Related]
18. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease.
Ringland C; Schweig JE; Paris D; Shackleton B; Lynch CE; Eisenbaum M; Mullan M; Crawford F; Abdullah L; Bachmeier C
Neurobiol Aging; 2020 Nov; 95():56-68. PubMed ID: 32758917
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice.
Tempier A; He J; Zhu S; Zhang R; Kong L; Tan Q; Luo H; Kong J; Li XM
Curr Alzheimer Res; 2013 Feb; 10(2):199-206. PubMed ID: 22950914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
